{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:38:24Z","timestamp":1794883104592,"version":"4.9.1"},"reference-count":103,"publisher":"European Respiratory Society (ERS)","issue":"165","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2022,5,23]]},"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:p>Pulmonary hypertension (PH) is known to complicate various forms of interstitial lung disease (ILD), including idiopathic pulmonary fibrosis, the interstitial pneumonias and chronic hypersensitivity pneumonitis. Pathogenesis of PH-ILD remains incompletely understood, and probably has overlap with other forms of pre-capillary pulmonary hypertension. PH-ILD carries a poor prognosis, and is associated with increased oxygen requirements, and a decline in functional capacity and exercise tolerance. Despite most patients having mild\u2013moderate pulmonary hypertension, more severe pulmonary hypertension and signs of right heart failure are observed in a subset of cases. Clinical suspicion and findings on pulmonary function, computed tomography and echocardiography are often the initial steps towards diagnosis. Definitive diagnosis is obtained by right heart catheterisation demonstrating pre-capillary pulmonary hypertension. Drugs approved for pulmonary arterial hypertension have been investigated in several randomised controlled trials in PH-ILD patients, leading to discouraging results until the recent INCREASE study. This review provides an overview of the current understanding, approach to diagnosis and recent advances in treatment.<\/jats:p>","DOI":"10.1183\/16000617.0220-2021","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T08:05:12Z","timestamp":1657699512000},"page":"210220","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["Recent advances in the management of pulmonary hypertension with interstitial lung disease"],"prefix":"10.1183","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-0361","authenticated-orcid":false,"given":"Aaron B.","family":"Waxman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yochai","family":"Adir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-2892","authenticated-orcid":false,"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-7391","authenticated-orcid":false,"given":"Sergio","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"2024102404043309000_31.165.210220.1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccm.2013.08.004","article-title":"Pulmonary hypertension due to lung disease and\/or hypoxia","volume":"34","author":"Nathan","year":"2013","journal-title":"Clin Chest Med"},{"key":"2024102404043309000_31.165.210220.2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1742-1241.2008.01624.x","article-title":"Pulmonary hypertension in interstitial lung disease","volume":"160","author":"Nathan","year":"2008","journal-title":"Int J Clin Pract Suppl"},{"key":"2024102404043309000_31.165.210220.3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.chest.2020.04.046","article-title":"The trouble with group 3 pulmonary hypertension in interstitial lung disease: dilemmas in diagnosis and the conundrum of treatment","volume":"158","author":"King","year":"2020","journal-title":"Chest"},{"key":"2024102404043309000_31.165.210220.4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MCP.0000000000000790","article-title":"Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment","volume":"27","author":"Behr","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"2024102404043309000_31.165.210220.5","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00002713"},{"key":"2024102404043309000_31.165.210220.6","doi-asserted-by":"crossref","unstructured":"Rahaghi FF , Kolaitis NA , Adegunsoye A , et al. Screening strategies for pulmonary hypertension in patients with interstitial lung disease: a multidisciplinary Delphi study. Chest 2022; in press [https:\/\/doi.org\/10.1016\/j.chest.2022.02.012]. doi:10.1016\/j.chest.2022.02.012","DOI":"10.1016\/j.chest.2022.02.012"},{"key":"2024102404043309000_31.165.210220.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.06.014"},{"key":"2024102404043309000_31.165.210220.8","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0076-2018"},{"key":"2024102404043309000_31.165.210220.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.3.746"},{"key":"2024102404043309000_31.165.210220.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.6_suppl.616S-a"},{"key":"2024102404043309000_31.165.210220.11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-3087"},{"key":"2024102404043309000_31.165.210220.12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0116"},{"key":"2024102404043309000_31.165.210220.13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00107206"},{"key":"2024102404043309000_31.165.210220.14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccl.2016.04.003","article-title":"Group III pulmonary hypertension: pulmonary hypertension associated with lung disease: epidemiology, pathophysiology, and treatments","volume":"34","author":"Klinger","year":"2016","journal-title":"Cardiol Clin"},{"key":"2024102404043309000_31.165.210220.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000532"},{"key":"2024102404043309000_31.165.210220.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.06.007"},{"key":"2024102404043309000_31.165.210220.17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.55.091902.103810"},{"key":"2024102404043309000_31.165.210220.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(99)90114-2"},{"key":"2024102404043309000_31.165.210220.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-011-0762-2"},{"key":"2024102404043309000_31.165.210220.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10092055"},{"key":"2024102404043309000_31.165.210220.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201105-0927OC"},{"key":"2024102404043309000_31.165.210220.22","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.1.9807024"},{"key":"2024102404043309000_31.165.210220.23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1378\/chest.111.4.1142-a","article-title":"Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension","volume":"111","author":"Harari","year":"1997","journal-title":"Chest"},{"key":"2024102404043309000_31.165.210220.24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.5858\/arpa.2017-0463-OA","article-title":"Morphometric study of pulmonary arterial changes in pulmonary Langerhans cell histiocytosis","volume":"142","author":"Bois","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"2024102404043309000_31.165.210220.25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00038709"},{"key":"2024102404043309000_31.165.210220.26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00021005"},{"key":"2024102404043309000_31.165.210220.27","first-page":"460","article-title":"Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation","volume":"16","author":"Harari","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"2024102404043309000_31.165.210220.28","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00093111"},{"key":"2024102404043309000_31.165.210220.29","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.042838"},{"key":"2024102404043309000_31.165.210220.30","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"2024102404043309000_31.165.210220.31","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01537-2014"},{"key":"2024102404043309000_31.165.210220.32","doi-asserted-by":"crossref","unstructured":"Piccari L , Wort SJ , Meloni F , et al . The effect of borderline pulmonary hypertension on survival in chronic lung disease. Respiration 2021; in press [https:\/\/doi.org\/10.1159\/000524263]. 10.1159\/000524263","DOI":"10.1159\/000524263"},{"key":"2024102404043309000_31.165.210220.33","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.5.1460"},{"key":"2024102404043309000_31.165.210220.34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1152\/jappl.1957.11.2.290","article-title":"Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries","volume":"11","author":"Roughton","year":"1957","journal-title":"J Appl Physiol"},{"key":"2024102404043309000_31.165.210220.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.12.011"},{"key":"2024102404043309000_31.165.210220.36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1475"},{"key":"2024102404043309000_31.165.210220.37","doi-asserted-by":"crossref","first-page":"e78001","DOI":"10.1371\/journal.pone.0078001","article-title":"Relevance of partitioning D LCO to detect pulmonary hypertension in systemic sclerosis","volume":"8","author":"Sivova","year":"2013","journal-title":"PLoS One"},{"key":"2024102404043309000_31.165.210220.38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2324"},{"key":"2024102404043309000_31.165.210220.39","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350709"},{"key":"2024102404043309000_31.165.210220.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.05.012"},{"key":"2024102404043309000_31.165.210220.41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/art.39528","article-title":"Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension","volume":"68","author":"Antoniou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2024102404043309000_31.165.210220.42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.hlc.2020.10.009","article-title":"Correlation between Doppler echocardiography and right heart catheterisation-derived systolic and mean pulmonary artery pressures: determinants of discrepancies between the two methods","volume":"30","author":"Sonaglioni","year":"2021","journal-title":"Heart Lung Circ"},{"key":"2024102404043309000_31.165.210220.43","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200210-1130OC"},{"key":"2024102404043309000_31.165.210220.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.07.073"},{"key":"2024102404043309000_31.165.210220.45","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.4.972"},{"key":"2024102404043309000_31.165.210220.46","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200811-1691OC"},{"key":"2024102404043309000_31.165.210220.47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/resp.13250","article-title":"Pulmonary hypertension in interstitial lung disease: limitations of echocardiography compared to cardiac catheterization","volume":"23","author":"Keir","year":"2018","journal-title":"Respirology"},{"key":"2024102404043309000_31.165.210220.48","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/crj.12608","article-title":"Pulmonary hypertension in advanced lung diseases: echocardiography as an important part of patient evaluation for lung transplantation","volume":"12","author":"Nowak","year":"2018","journal-title":"Clin Respir J"},{"key":"2024102404043309000_31.165.210220.49","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1545OC"},{"key":"2024102404043309000_31.165.210220.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.11.020"},{"key":"2024102404043309000_31.165.210220.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.11.012"},{"key":"2024102404043309000_31.165.210220.52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.rmed.2014.12.011","article-title":"Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: an algorithm application model","volume":"109","author":"Ruocco","year":"2015","journal-title":"Respir Med"},{"key":"2024102404043309000_31.165.210220.53","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01532-2015"},{"key":"2024102404043309000_31.165.210220.54","first-page":"37","article-title":"Correlation between the pulmonary artery pressure measured in echocardiography and pulmonary artery diameter in the CT-scan of patients suffering from interstitial lung disease","volume":"10","author":"Fakharian","year":"2011","journal-title":"Tanaffos"},{"key":"2024102404043309000_31.165.210220.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2015.04.008"},{"key":"2024102404043309000_31.165.210220.56","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-520OC"},{"key":"2024102404043309000_31.165.210220.57","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200302-219OC"},{"key":"2024102404043309000_31.165.210220.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.04.002"},{"key":"2024102404043309000_31.165.210220.59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-488OC"},{"key":"2024102404043309000_31.165.210220.60","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200405-578OC"},{"key":"2024102404043309000_31.165.210220.61","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00131813"},{"key":"2024102404043309000_31.165.210220.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.07.022"},{"key":"2024102404043309000_31.165.210220.63","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0355-2020"},{"key":"2024102404043309000_31.165.210220.64","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01914-2018"},{"key":"2024102404043309000_31.165.210220.65","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00016913"},{"key":"2024102404043309000_31.165.210220.66","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-1-29"},{"key":"2024102404043309000_31.165.210220.67","doi-asserted-by":"publisher","DOI":"10.1159\/000345221"},{"key":"2024102404043309000_31.165.210220.68","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.112847"},{"key":"2024102404043309000_31.165.210220.69","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01483-2021"},{"key":"2024102404043309000_31.165.210220.70","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0080-2016"},{"key":"2024102404043309000_31.165.210220.71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1164\/arrd.1985.131.4.493","article-title":"Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease","volume":"131","author":"Weitzenblum","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2024102404043309000_31.165.210220.72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604344"},{"key":"2024102404043309000_31.165.210220.73","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1164\/rccm.202009-3608ST","article-title":"Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline","volume":"202","author":"Jacobs","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404043309000_31.165.210220.74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chest.2020.01.049","article-title":"Ambulatory oxygen in fibrotic interstitial lung disease: a pilot, randomized, triple-blinded, sham-controlled trial","volume":"158","author":"Khor","year":"2020","journal-title":"Chest"},{"key":"2024102404043309000_31.165.210220.75","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102404043309000_31.165.210220.76","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200705-732OC"},{"key":"2024102404043309000_31.165.210220.77","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/art.27466","article-title":"Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis","volume":"62","author":"Seibold","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2024102404043309000_31.165.210220.78","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002110"},{"key":"2024102404043309000_31.165.210220.79","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1874OC"},{"key":"2024102404043309000_31.165.210220.80","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00104612"},{"key":"2024102404043309000_31.165.210220.81","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-9-201305070-00003"},{"key":"2024102404043309000_31.165.210220.82","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0446OC"},{"key":"2024102404043309000_31.165.210220.83","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa1811737","article-title":"Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis","volume":"379","author":"Kolb","year":"2018","journal-title":"N Engl J Med"},{"key":"2024102404043309000_31.165.210220.84","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study","volume":"7","author":"Nathan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102404043309000_31.165.210220.85","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.chest.2020.02.016","article-title":"A randomized, double-blind, placebo-controlled study of pulsed, inhaled nitric oxide in subjects at risk of pulmonary hypertension associated with pulmonary fibrosis","volume":"158","author":"Nathan","year":"2020","journal-title":"Chest"},{"key":"2024102404043309000_31.165.210220.86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2213-2600(20)30356-8","article-title":"Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102404043309000_31.165.210220.87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008470"},{"key":"2024102404043309000_31.165.210220.88","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.healun.2021.01.342","article-title":"Macitentan in pulmonary hypertension (PH) due to chronic lung disease: real-world evidence from OPUS\/OrPHeUS","volume":"40","author":"Sahay","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"2024102404043309000_31.165.210220.89","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1594"},{"key":"2024102404043309000_31.165.210220.90","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1164\/rccm.201903-0488OC","article-title":"Nintedanib and sildenafil in patients with idiopathic pulmonary fibrosis and right heart dysfunction. A prespecified subgroup analysis of a double-blind randomized clinical trial (INSTAGE)","volume":"200","author":"Behr","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404043309000_31.165.210220.91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.rmed.2018.03.019","article-title":"Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a phase IIb, randomised, double-blind, placebo-controlled study \u2013 rationale and study design","volume":"138","author":"Behr","year":"2018","journal-title":"Respir Med"},{"key":"2024102404043309000_31.165.210220.92","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S2213-2600(21)00165-X","article-title":"Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post hoc analysis of the INCREASE study","volume":"9","author":"Nathan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102404043309000_31.165.210220.93","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S2213-2600(21)00264-2","article-title":"Inhaled trepostinil for severe fibrotic interstitial lung disease: grounds for cautious optimism?","volume":"9","author":"Harari","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102404043309000_31.165.210220.94","doi-asserted-by":"crossref","first-page":"2045894019881954","DOI":"10.1177\/2045894019881954","article-title":"Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice","volume":"9","author":"Nikitopoulou","year":"2019","journal-title":"Pulm Circ"},{"key":"2024102404043309000_31.165.210220.95","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41598-018-19294-1","article-title":"Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation","volume":"8","author":"Lambers","year":"2018","journal-title":"Sci Rep"},{"key":"2024102404043309000_31.165.210220.96","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00408-017-0081-7","article-title":"Inhaled treprostinil in pulmonary hypertension associated with lung disease","volume":"196","author":"Faria-Urbina","year":"2018","journal-title":"Lung"},{"key":"2024102404043309000_31.165.210220.97","doi-asserted-by":"publisher","DOI":"10.1159\/000242498"},{"key":"2024102404043309000_31.165.210220.98","doi-asserted-by":"crossref","unstructured":"McNamara RJ , McKeough ZJ , McKenzie DK , et al. Water-based exercise training for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013: CD008290. doi:10.1002\/14651858.CD008290.pub2","DOI":"10.1002\/14651858.CD008290.pub2"},{"key":"2024102404043309000_31.165.210220.99","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00053512"},{"key":"2024102404043309000_31.165.210220.100","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00111811"},{"key":"2024102404043309000_31.165.210220.101","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00193411"},{"key":"2024102404043309000_31.165.210220.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.11.014"},{"key":"2024102404043309000_31.165.210220.103","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00081512"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0220-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:05:10Z","timestamp":1740373510000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0220-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":103,"journal-issue":{"issue":"165","published-online":{"date-parts":[[2022,7,12]]},"published-print":{"date-parts":[[2022,9,30]]}},"alternative-id":["10.1183\/16000617.0220-2021"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0220-2021","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]}}}